PT MITSUBISHI TANABE PHARMA INDONESIA

PT Mitsubishi Tanabe Pharma Indonesia is primarily a manufacturer of pharmaceutical products.

Company Introduction:

PT Mitsubishi Tanabe Pharma Indonesia is a pharmaceutical company located in Indonesia. It operates as a subsidiary of Mitsubishi Tanabe Pharma Corporation, a prominent Japanese research-based pharmaceutical company. The Indonesian entity is involved in the manufacturing, development, and distribution of a variety of pharmaceutical products within the country. Its product portfolio often targets therapeutic areas such as central nervous system disorders, metabolic diseases, and immunology. The company's mission is to enhance public health in Indonesia by offering innovative and high-quality medicines, leveraging its parent company's global expertise and research capabilities.

Here are some of the products PT Mitsubishi Tanabe Pharma Indonesia manufactures or sells:

* **Brain Metabolizing Activator:** Cerebroprotein Hydrolysate

* **Anti-Alzheimer's:** Donepezil HCl

* **Antiplatelet:** Cilostazol

* **Antidiabetic:** Metformin HCl, Glibenclamide, Pioglitazone HCl

* **Antihypertensive:** Olmesartan Medoxomil

* **Immunosuppressant:** Tacrolimus

* **Uric Acid Reducer:** Febuxostat

* **Injectables:** Various Injectable Products